NGL FINECHEM
Back to Cashflow Statement
|
NGL FINECHEM Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹0.19 Cr | ₹-7.43 Cr | ₹7.18 Cr | ₹-1.46 Cr | ₹1.70 Cr |
What is the latest Net Cash Inflow / Outflow ratio of NGL FINECHEM ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹0.19 Cr |
| Mar2024 | ₹-7.43 Cr |
| Mar2023 | ₹7.18 Cr |
| Mar2022 | ₹-1.46 Cr |
| Mar2021 | ₹1.70 Cr |
How is Net Cash Inflow / Outflow of NGL FINECHEM Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.19 Cr | Positive | |
| Mar2024 | ₹-7.43 Cr | Negative | |
| Mar2023 | ₹7.18 Cr | Positive | |
| Mar2022 | ₹-1.46 Cr | Negative | |
| Mar2021 | ₹1.70 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,906.0 Cr | -1.2% | 27.3% | 185.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,794.0 Cr | 1.7% | -2.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,956.0 Cr | 2% | -2.2% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,820.0 Cr | -1.8% | -0.1% | 36.7% | Stock Analytics | |
| CIPLA | ₹109,370.0 Cr | -2% | -3.3% | -9.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,133.0 Cr | -0.6% | -3.8% | -6.9% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | -1.2% |
27.3% |
185.5% |
| SENSEX | 1.7% |
2.1% |
-6% |
You may also like the below Video Courses